| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |